PTP-001 (MOTYS™)

· Doron Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PTP-001 (MOTYS™), covering 2022-07-19 to 2025-12-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safey of PTP-001 (MOTYS™) in Knee Osteoarthritis Patients [Phase 3]